Skip to content
GERICLINICS

GeriQBank · Paper II · Q9

Subarachnoid Haemorrhage

Not rated7-mark answer
Chapter
Cerebrovascular Disease
Years asked
Not recorded in the source
Frequency
No university frequency data for this paper yet

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark answer before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Answer

Textbook Core – 6 Points

1.

Definition and causes. Bleeding into the subarachnoid space. About 85% follow rupture of a saccular (berry) aneurysm — anterior communicating > posterior communicating > middle cerebral bifurcation; 10% are perimesencephalic non-aneurysmal (benign course); the remainder are due to AVM, trauma, vasculitis, coagulopathy or reversible cerebral vasoconstriction syndrome. Risk factors: hypertension, smoking, alcohol, family history, adult polycystic kidney disease and connective tissue disorders.

2.

Clinical features. Sudden “worst headache of my life” (thunderclap headache) peaking within seconds, with vomiting, neck stiffness, photophobia, transient loss of consciousness and seizures. A sentinel or warning bleed precedes the major event in up to 40%. Fundoscopy may show subhyaloid or vitreous (Terson) haemorrhage. In the elderly the presentation is often atypical — confusion, collapse or coma with less prominent headache and meningism.

3.

Grading. Hunt and Hess (I — mild headache/nuchal rigidity, through V — deep coma and decerebrate posturing) and the WFNS scale (based on GCS plus motor deficit) grade clinical severity; the modified Fisher scale grades the volume and distribution of blood on CT and predicts vasospasm.

4.

Diagnosis. Immediate non-contrast CT head — sensitivity exceeds 95% within the first 6 hours and falls steadily thereafter. If the CT is negative and suspicion persists, perform a lumbar puncture after 12 hours, looking for xanthochromia (ideally by spectrophotometry) and a red cell count that does not clear between successive bottles. Then CT angiography or digital subtraction angiography to define the aneurysm.

5.

Treatment. Admit to a neurocritical care unit. Secure the aneurysm within 24 hours by endovascular coiling (preferred — ISAT showed better outcomes) or surgical clipping. Bed rest, analgesia, stool softeners; control blood pressure before the aneurysm is secured (systolic <160 mmHg) while avoiding hypotension; nimodipine 60 mg orally every 4 hours for 21 days to prevent delayed cerebral ischaemia; maintain euvolaemia and normonatraemia. Antiepileptics only if seizures occur.

6.

Complications. Rebleeding (peaks in the first 24 hours; the highest-mortality complication); delayed cerebral ischaemia from vasospasm (days 4–14); hydrocephalus — acute obstructive needing an external ventricular drain, and chronic communicating needing a VP shunt; hyponatraemia from cerebral salt wasting or SIADH; neurogenic pulmonary oedema; stunned myocardium / Takotsubo cardiomyopathy with ECG changes and raised troponin; seizures; and long-term cognitive and mood impairment. Overall mortality is 30–40%.

Latest Update – 1 Point

7.

AHA/ASA 2023 Guideline for Aneurysmal Subarachnoid Haemorrhage (replacing the 2012 guideline). Key positions: treat the ruptured aneurysm preferably within 24 hours, aiming for complete obliteration; early enteral nimodipine is beneficial; prophylactic hypervolaemia and haemodynamic augmentation are harmful and should NOT be used (Class 3: Harm) — maintain euvolaemia instead, and induce hypertension only once symptomatic delayed cerebral ischaemia develops; routine statin therapy and intravenous magnesium are not recommended; and outcomes are better when patients are managed in high-volume centres with dedicated neurocritical care units, so timely transfer is recommended.

Current Practice Update

Item Position

Textbook “Triple-H therapy” — hypertension, hypervolaemia and haemodilution — is used to prevent and treat vasospasm. Statins and magnesium are considered.

Current AHA/ASA 2023: prophylactic hypervolaemia and haemodynamic augmentation are harmful. Maintain recommendation euvolaemia; induce hypertension only for symptomatic delayed cerebral ischaemia. Routine statins and IV magnesium are not recommended.

Exam approach Write the classical account, then add: “Triple-H therapy has been abandoned; the AHA/ASA 2023 guideline recommends euvolaemia, with induced hypertension reserved for established DCI.”

Examiner’s Tip — Verbatim Mark-Earning Lines

“A normal CT does not exclude subarachnoid haemorrhage — do an LP after 12 hours and look for xanthochromia.” “Nimodipine improves outcome without abolishing angiographic vasospasm — it is neuroprotective, not simply a vasodilator.”

“Rebleeding kills early; vasospasm kills between days 4 and 14.”

Skeleton: Definition/aneurysm → Thunderclap headache → Hunt-Hess/WFNS/Fisher → CT then LP then angiography → Coiling + nimodipine → Complications → AHA/ASA 2023.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page